Since all businesses face similar challenges, we use The Research Cloud™ to conduct our own
research and gather these insights so you don’t have to. We answer the most important questions so that you can keep a steady pulse on all your markets.
The impact of a major vendor, which has thousands of hospital and clinic customers, getting acquired cannot be overstated. That is certainly the case with Optum (a division of UnitedHealth Group) acquiring Change Healthcare. To that point, we decided to do some quick research with those this event impacts the most – decision-makers and clinicians. This is their story…
Even before the much-anticipated fall resurgence of Covid-19, there has been significant speculation about the potential emergence of a powerful Covid-19 + Influenza dual threat going into fall/winter – a “twindemic.” We did a very quick pulse check with healthcare professionals across the country to better understand whether the issue is an actual concern and the potential ramifications of such an event.
The usage of virtual health solutions was already on the rise before the pandemic hit but since then this segment has skyrocketed. In August Livongo agreed to be acquired by Teladoc for $18.5B and the deal was finalized on October 30th, 2020. Given the rapidly increasing importance of virtual health and this merger’s potential impact, we executed a very quick pulse check with healthcare professionals.
AI continues to be a hot topic in healthcare, specifically as it relates to medical imaging. We’ve been researching AI adoption trends for the past 3 years and wanted to get a quick pulse from radiology and medical imaging professionals to see what’s changed.
This time we specifically wanted to see what kind of value or ROI their departments are realizing from adopting AI and to see why some organizations haven’t yet taken the plunge.
What’s happening in healthcare right now is unprecedented. This typically inelastic industry is experiencing a downturn to a shocking degree. Almost every provider organization has taken a serious hit. This report uncovers the level hospitals and clinics have been impacted, where they’re spending money now and in the future, and what they predict will happen in 2021.
75 healthcare institutions (representing hundreds of facilities) from around the USA participated in our research during a 10 day period in mid-May 2020. Participants came primarily from two decision making leadership groups – clinicians (CMOs, CNOs, and Nursing Directors) and operations (procurement, materials management, and supply-chain).
550+ healthcare leaders provided insights via our Research Cloud®, regarding about which health systems they feel lead the way in innovation, delivery transformation, and improving quality while containing costs. We also collected information about how these decisions makers feel about those institutions from a reputation standpoint. This is the 4th year we’ve conducted this research and the trends took a fascinating turn this year.
On January 9th, 2020, Governor Gavin Newsom announced that California would become the first state to make its own generic pharmaceuticals. His intention is, in his own words, to “take the power out of the hands of greedy pharmaceutical companies.” His proposal could have a big impact on Hospitals, Health Systems, Physicians, and Patients if it is implemented; not only in California, but across the United States if other states follow suit.
COVID-19 is here and, in some respects, it’s everywhere. Its impact, on nearly every aspect of society, is practically unprecedented. Because of this, we wanted to know how healthcare providers are dealing with this crisis, what are they learning, and what steps can be realistically taken to (much) better handle a similar pandemic in the future.
Physicians, nurses, and other pertinent healthcare leaders from 260 organizations provided insights and information for this research.
The largest seismic event since the initial HITECH legislation is about to hit healthcare. The U.S. Department of Health and Human Services (HHS) recently proposed a rule that, in their words, will “support seamless and secure access, exchange, and use of electronic health information”. This rule is being termed the “information blocking rule” by many in the industry.
Because of the material impact this information blocking rule will have primarily on healthcare provider organizations and secondarily on healthcare IT vendors, we launched research in mid-February 2020 to healthcare decision makers and influencers. We wanted to understand how these healthcare providers and executives feel about the information blocking rule.
While wandering around RSNA we heard a lot of comments from attendees about the conference – some good, some bad. It got us thinking about our years of attendance and what we’ve come away with from these shows and how our experiences compare with others. So we decided to launch some research in early December 2019 to see how others feel about RSNA (and trade shows in general). Here’s what we found out…
Walmart recently announced that it will open stand-alone facilities to offer primary care, dental, optometry, counseling, lab tests, X-rays, hearing, wellness education, and behavioral health. Prices will be transparent. Patients can pay cash, and insurance will be accepted.
We reached out to individuals from provider organizations asking them to share their opinions on what Walmart is doing, as well as their thoughts on how effective Walmart could be as a healthcare provider and how they believe this will have an impact on their organization.
For the past 4 years we’ve been collecting data on what configuration of core radiology IT solutions (PACS, VNA, Web Viewer) radiology and medical imaging leadership prefer to use in their departments. During this time we’ve received input from over 900 organizations including 164 just last month (October 2019).
Seeing as how social determinants of health (SDoH) involves much more than just one area of a community, we wanted to involve as many leadership groups from different healthcare verticals and organization types. This study is comprised of engagement from 61 decision makers in various roles at provider organizations around the country. It looks at what areas of SDoH being addressed, resources dedicated to SDoH, and what some of the biggest benefits and barriers are in focusing on improving the quality of life in the communities surrounding each organization.
Patient Engagement is an ever-increasing topic of discussion within healthcare. The problem, like with any hyped technology, is everyone has a different view of what patient engagement actually is. Some think it has to do with wearables and personal health, others might think it’s how to get a one-time follow-up survey after an appointment, or even ongoing interaction between patients and physicians. What makes it tricky is that it’s kind of a combination of all of those things.
With so much digital disruption taking root in healthcare (for example, Epic’s partnership with Apple), it was only a matter of time before two of the larger scale players partnered together. Cerner and Amazon signing a long-term strategic partnership is one of those newsworthy events that typically demands attention.
On June 24, 2019 President Trump issued an Executive Order that is meant to accelerate the emergence of price transparency for patients. Through our research cloud, we gathered research from 286 healthcare leaders over a 7 day period. As is typical when we do this kind of research, the most enthusiastic demographic continues to be those who work for provider organizations with physicians being the group principally interested in President Trump’s Executive Order. The insights we garnered from payers, suppliers, and Big Pharma are interesting yet primarily anecdotal in nature.
Recently we’ve been noticing a disturbing trend – political tribalism, more and more overdoses, unhealthy amounts of screentime, and similar social dysfunctions. These types of trends often fuel the research we do with providers, vendors, health plans, and life sciences companies. Some of the questions we’ve heard, and conversations we’ve had, deal with mental health issues and why they appear to be on the rise. Our Research Cloud® provided immediate access to the right individuals who shared their insights to these critical questions.
There is a lot of hype about moving traditional on-premise solutions to the cloud but most healthcare organizations are only doing so gradually and, in many instances, hesitantly. This industry brief covers just a few of the lessons we’ve learned from research we’ve been doing on cloud adoption.
The Greek philosopher Heraclitus once said “The only thing that is constant is change.” Well, when it comes to healthcare, we’ve got change in spades. In recent years, we’ve witnessed a spate of provider consolidation and healthcare technology company consolidation. Provider organizations know better than anyone that consolidation is just one of many forces pushing provider orgs to spend or even re-spend on their technology solutions. We wanted to know which technologies providers are considering, which solutions they may be replacing and why.
When news of a noteworthy merger or acquisition breaks, Reaction Data is first on the scene with thoughts from the market and customers. In a 24 hour period we had over 200 participants weigh in on the announcement that Philips plans to acquire Carestream’s Health IT business.
341 healthcare leaders provided insights via our Research Cloud®, regarding hospital organizations that are top-of-mind to them. They were asked which provider organization comes to mind as being a model for innovation, providing quality care a sustainable cost, and acts as a thought leader on topics related to healthcare transformation. Participants were given no prompts and were simply allowed to select whichever organization they wished for reasons that were important to them.
3M recently announced their acquisition of the technology arm of M*Modal, potentially creating a powerful competitor in this space. In light of this, we wanted to know what the market, and customers, thought the impact would be.
Machine Learning is one of the hottest topics in healthcare today, especially in medical imaging. It promises to provide efficiencies in several areas with the expectation of improving quality while decreasing costs.
In recent months we’ve had thousands of providers engage with the Research Cloud. One question they provide insights on is that of emerging technologies, and which ones would be most useful. Telemedicine typically makes the shortlist. Recently, the Centers for Medicare and Medicaid Services (CMS) announced plans to increase reimbursements for remote visits. Naturally, a few questions come to mind. Who is aware of the CMS news, whether telemedicine is continuing to gather steam, what the adoption rates are, which vendors they are using, and what the benefits are to name a few. But perhaps most importantly, are patients even interested and will they use such an option?
Mergers and Acquisitions are becoming the new normal in healthcare, but Virence merging with athenahealth might take the cake in terms of being unique. A quick History lesson…
In July, Veritas Capital acquired GE Healthcare’s revenue cycle, ambulatory care, and workforce management product lines, and then several months later rebrands it as Virence. On November 12, it was announced that Veritas Capital and Elliott Management will take athenahealth private and merge it with Virence. Given the magnitude, and relative uniqueness, of this M&A event we decided to use our Research Cloud to collect feedback from affected (and interested) hospitals and clinics, and during the week of November 18th, 2018 we collected research from 150+ organizations. This is their story…
The rumors of PACS death have been greatly exaggerated. PACS has been, and still is, very much the hub of the radiology department. Radiology continues to be the early adopter of technology in most hospitals.
Many trends have emerged over time – some have faded quickly while others have take hold and had a long-lasting impact. One of the latest is the notion of Deconstructed PACS which at its core is a best-of-breed approach. So in essence, use different solutions (PACS, VNA, Viewers) from multiple vendors than go with a single-source vendor approach. There’s been a lot of buzz about this new model, but is it one that will be applied across the industry or is it ideal for a specific type of healthcare institution?
Those in radiology are truly the pioneers of speech recognition technology. The department has traditionally been the earliest adopter of new tools in healthcare. They went from film to viewing and storing their images on PACS. When the opportunity presented itself to jump from the dictation train, they opened their arms to speech recognition.
While it’s debatable whether Nuance had a technological advantage, they were one of the first with a solution and aggressively developed partnerships with PACS, RIS and EHR vendors. In this brief, we find that all of the vendors are doing a solid job but Nuance continues to dominate the market in terms of customers.
We’ve all heard our fair share of horror stories from someone who is prescribed the wrong medication, or even misdiagnosed. While we’re all a little weary of computers taking over the world, they can certainly provide an added level of peace to both patients and physicians.
Clinical decision support (CDS) systems are used to help providers make better and quicker decisions at the point of care. Like most technologies, their useful and convenient abilities do not come without their own list of struggles. Many companies will employ a stand-alone CDS solution, and while they are great at what they do, can be hard to integrate with the provider’s EHR.
Speech recognition is not new technology. Despite the fact that it’s an effective, proven tool that has improved the lives of countless healthcare providers, there’s still a surprising number of individuals who think their organization will never adopt a speech recognition solution.That being said, we reached out to providers to see if we could get a better picture of where speech recognition is going.
The healthcare IT landscape continues to change. One minute you’re convinced the world is round and then a series of new technological advancements, entrants into the market, and mergers and acquisitions give it the appearance of being flat. Then news breaks and it becomes a Rubik’s cube with twists and turns so complex it’s unclear if you’ll ever be able to solve it.
Because of the flurry of activity in the last few months, Reaction Data went out to provider organizations and garnered feedback from nearly a hundred leaders. In this brief, we find out which companies these leaders think will have the biggest impact on healthcare and why. We also look at some of the areas the key players are trying to break into.
“Let’s start with the first benefit to nursing: Altruism – the unselfish concern for the welfare of others; selflessness. Nurses help people. It’s that simple. And in doing so, we receive the unmatched satisfaction of knowing that we have made a difference to patients and their families.” – Dawn Marino, RN, BSN, HNB-BC: – Why Did You Become a Nurse? “Nurses help people.” So, what’s standing in the way of nurses performing the job they went into the field to do? Reaction Data asked nurses from across the nation what the major contributors to the work-related stress they feel are. Spoiler alert: It’s not the patients.
“If things don’t change, I am taking early retirement.” That was the sentiment from a physician in a Midwestern hospital. Sadly, she’s not alone. When posed with the question as to what is causing burnout, several physicians told us the solution was retirement. Others expressed passion about fixing a broken system. Reaction heard from over 250 physicians across the nation to find out what is causing them stress and, more importantly, what they would prescribe to heal it.
Over the past few years, mergers and acquisitions in healthcare have noticeably increased in frequency. Providers have been purchasing other providers, vendors purchasing other vendors, and even payers or their parent organizations purchasing providers and vendors alike. Examples include Aetna acquiring Healthagen, Humana’s home health purchase of Kindred at Home, and recently, Optum’s acquisition of The Advisory Board. (Optum is owned by UnitedHealth Group, which also owns UnitedHealthcare).
Prescription drug prices are rising at an alarming rate. In 2016, total drug costs went up about three times the rate for other goods and services, according to the U.S. Department of Labor. About 20 percent of generics have had price hikes of at least 100 percent between 2013 and 2017, according to analysis by the Drug Channels Institute. And, as recently reported by CBS news magazine 60 Minutes, a drug used to treat infantile spasms that in 2001 cost $40 a vial, now costs $40,000.
Earlier this year, plans for the most disruptive venture within the healthcare industry in the last decade was announced: a collaborative not-for-profit generic drug company called Project RX which consists of four health systems; Ascension, Intermountain Healthcare, SSM Health, and Trinity Health, in consultation with the US Department of Veterans Affairs was formed.
Amazon is seeking to disrupt the traditional healthcare supply chain by selling everything from bandages to hip replacements to syringes. They plan to expand their B2B marketplace to allow hospitals and clinics to shop for supplies they need to stock various departments and locations. It would extend the advantages of their consumer site to hospital systems, including lower costs, simplified purchasing, and getting rid of middle men.
Earlier this year, Anthem Insurance Companies, Inc. announced that it will be reviewing their members’ emergency department visits. If the condition they are being seen for is deemed non-emergent, Anthem may not cover the ED visit. “Anthem States” cut a wide swath. Those affected are members in CO, CT, NV, GA, IN, KY, MI, MO, NH, OH, VA, and WI. This research looks at how this new policy will affect providers and patients in the affected states as well as feedback from providers in other states across the country.
Near the end of 2016, we organized a study to determine results about brand recognition and reputation among the top hospital organizations throughout the US. Because of such an exciting response, and increased interest from the market, we decided to do follow-up research and see what might have changed since then. Throughout the brief you can see how the two studies compare and spot the trends.
Machine Learning (an exciting sector of the artificial intelligence universe) is garnering an enormous amount of attention in every industry, and healthcare certainly is no exception. Almost every analyst firm, think tank, advisory outfit worth its salt states that AI, and specifically machine learning, is here to stay. More to the point, there are dozens of new companies claiming machine learning acumen especially in the field of medical imaging. At RSNA 2017 the most prevalent topic was machine learning and how much of an impact it will really have on the practice of medicine and on the business of healthcare overall.
A great way to start an argument is to bring up the topic of an EHR (electronic health record) with a physician, but you’d never know it if you looked at almost any EHR report in the industry. That’s because the research in those reports comes from CIOs and other IT leadership. And while these individuals are certainly bright people with good intentions they, don’t have to use an EHR in their daily work schedule and as such their motivations are materially different than are the end users EHRs were intended for – i.e. physicians. That being the case, we decided to focus our research on just physician feedback on EHRs.
Current trends in radiology imaging are shifting at a rapid rate. The past few years have seen a bit of a shift where organizations using a one-stop shop approach for imaging solutions have begun considering a best-of-breed (deconstructed PACS) strategy instead. There hasn’t been a tectonic shift in this direction as of yet but there’s been enough “noise” to make the industry pay attention. While some organizations embrace the benefits of using multiple vendors, others prefer the accountability and relationship growth of a single vendor. This brief consolidates data received from 269 imaging professionals ranging in roles from Imaging and Radiology Directors to radiologists, and analyzes the companies they are using in order to better understand these shifts.
Telemedicine is a hot topic that’s getting hotter. In this brief we look at who will be adopting this new technology. We also include qualitative responses from respondents telling us why they are for or against telemedicine. The brief also covers current market presence, replacement rates, vendors winning/losing business, financial impacts and more.
What happens when a market matures around technology that fills a very real need? High adoption becomes the norm, industry leaders emerge, and inevitably some begin to dull as the shine of the latest and greatest technology wears off. In addition, there is always a small segment of the market that stubbornly holds out like a grandpa with a flip phone who makes a point to let everyone know how smartphones are overkill. This is the speech recognition market in radiology.
Speech recognition in cardiology perfectly illustrates the point that cardiology organizations are slower to adopt new technology compared to their counterparts in radiology. Fewer than one in four cardiology facilities having adopted a speech solution. Compare that to radiology with adoption rates north of 90%. However, those with stakes in the speech industry shouldn’t abandon the cardiology market, as we’re seeing the rate of adoption triple from the previous year and though advancements are happening, speech recognition is not a new technology by any stretch. So, what’s driving this increase in adoption?
Speech recognition adoption in pathology sits between radiology and cardiology. Adoption has taken years to catch on but appears to be reaching its stride with more than one-in-three participants in our research stating they use a speech solution. This bests cardiology which saw significant gains as well but still struggles to clear the one-in-four mark. Why the disparity between these two groups of providers? While both groups cite speech solutions not being accurate enough as the top reason for resisting adoption, this doesn’t appear to hold pathology organizations back as much as it does in cardiology.
Adoption of speech solutions integrated with organizations’ EHRs isn’t a new concept by any stretch, but seems to get less attention than other departmental speech solutions. However, with the continued expansion of electronic health records, the monumental task remains—how to create and update patient information as quickly and accurately as possible. The problems associated with speech solutions in EHRs is the timing of when it’s used.
In theory, M&As make a lot of sense, but the unintended consequences put what should be matches made in heaven at risk of going sideways. For example, how does a company, Allscripts in this case, avoid getting distracted from making meaningful improvements to their native products? With how unpopular acquisitions are among providers, how do you avoid making them feel like they play second fiddle to the bottom line? And, how do you integrate the two brands, solutions, and customers together?
It would seem the lab space is a relatively stable market, with the shift to EHR lab modules having largely run its course, but a high percent of providers suggests they are considering replacing their current solution. It’s also not unreasonable to expect continued (although modest) consolidation, as the writing may be on the wall for some best of breed LIS vendors, causing them to seriously consider finding suitors among the EHR vendors.
We’ve had senior leaders among prominent vendors essentially tell us that they don’t care about what frontline users have to say. From our perspective, this is both a shortsighted and slightly reckless position to take. Let’s not forget that there is power in numbers. In this case, nurses and nurse leaders weighing in on their EHRs.
Medical coding is one of those slow and steady areas in healthcare, yet indispensable for the longevity of provider organizations. This is evidenced by the snail-pace at which providers are adopting new technology designed to speed up and increase accuracy. Specifically, computer-assisted coding is starting to take hold but still has significant runway for growth. In our latest research, we examine trends in vendor market presence, vendor ratings (NPS), the coding replacement market and computer-assisted coding adoption.
Is there anything more polarizing in healthcare today than how we cover medical expenses? If there is a more divisive topic, we haven’t found it yet. Whether you are part of the promoter or detractor camps for a single-payer system, you will find interesting perspective on a topic that will not be untangled anytime soon.
There’s nothing like a good old-fashioned government mandate to make a market interesting. What was already a growth market of HIT, the mandate has supercharged, with two-thirds of radiology providers planning to pick up a solution before the end of the year. As a result, there are only two categories of suppliers in this space, winners and WINNERS. Download this industry brief to see more about provider’s plans and which vendors are poised to capitalize on the windfall the most.
The eClinicalWorks settlement had the Health IT world buzzing for a few days, but what long-term ripple effects will this have in healthcare? In our latest industry brief (which you can download below), we tap into our network leaders in outpatient facilities to discover the implications and received direct feedback from over 100 respondents about their familiarity with the settlement, the impact on the future relationship of current eCW clients and non-clients skepticism about their own EHR suppliers.
Hyland caught the attention of the healthcare industry with their recent acquisition of Lexmark. A big-time acquisition like this yields a significant influence throughout the industry. How will this impact their future business? We’ve collected data that stretches across both the US and the UK. Find out what providers from both countries have to say about the acquisition, and how it changes (or doesn’t change) their perspective of the newly formed company!
The market for revenue cycle management is ripe for a dramatic shift. 1 in 5 organizations seriously consider replacing their core RCM supplier. One half of those are replacing all solutions. With such a significant swing in the market eminent, which suppliers stand to gain? Dig into these RCM trends to discover who is poised to win new business.
The Brexit bus has been gone for a year now. While there may be some advantages to this occurrence, providers appear to be more pessimistic about the whole thing. In this industry brief we discuss some of the issues surrounding this topic. What happens to funding? How will it affect staffing? Will providers still have the same ability to purchase and upgrade equipment? All of these, along with many qualitative responses, are discussed in this Reaction Industry Brief!
An ideological battle stirs in the medical imaging world. While some argue that a single enterprise supplier is the best method, others contend that a best of breed, multiple supplier approach is preferable. Who is right? The UK weighs in on this heated debate by sharing with us a complete overview of their medical imagaing market.
Over 1,300 physicians weigh in on these two hot topics. Why do they refer their patients to certain locations? How likely are they to even refer their patients at all? Hospitals share with us their top determinants in making these important decisions, along with the value they place on the many features of self-scheduling.
Technology is an ever increasing influence in all aspects of life, but especially within healthcare. That being the case, we thought it would be very interesting to see how providers are spending their money. What IT systems are they prioritizing? Looking deeper into these HIT purchasing trends is a necessary step to understand the ever-evolving healthcare landscape.
“All companies will need to merge to survive the future.” That is just one of many qualitative responses we received from providers giving us their thoughts on the merger between McKesson and Change Healthcare. Find out what else providers have to say about these two companies becoming one. The Reaction Research Cloud has data from 146 respondents detailing all aspects of the merger. Check it out.
Few areas in healthcare are a tug-of-war more than the bitter feud between enterprise and best of breed imaging. Yes, we’re being dramatic and no there isn’t really a “bitter feud”. However, both groups hold strong opinions on the topic. In our latest imaging insights, we gathered feedback from 276 top decision-makers among care organizations across North America. What are their opinions on the subject, are they satisfied with their current imaging strategy and what solutions are they planning to replace?
What happens when a market matures around technology that fills a very real need? High adoption becomes the norm, industry leaders emerge, and inevitably some begin to dull as the shine of the latest and greatest technology wears off. This describes the speech recognition market in radiology. However, we see new trends taking shape this year that are sure to be of interest to speech recognition stakeholders. In this collection we received feedback from 375 healthcare leaders in radiology departments and diagnostic imaging centers across North America, allowing us a deep dive into the speech market in radiology regarding Net Promoter Scores, replacement rates, potential net growth, and more.
The world has embraced the power and importance of analytics, but we’re all still trying to wrap our collective head around the top methods, best practices, and tools needed to get every bit of value out of our data. So now the tricky part: How do we analyze it? Which solutions do we use? How well do they work? This analysis is focused on these questions. More than 200 applicable hospital leaders gave their input.
As we revisited the topic of clinical IT from one year ago (2015), a simple question keeps resurfacing: Are electronic patient records (EPR) having a meaningful impact in healthcare? And if so, does this positive impact outweigh the expense and added complexity to providers’ efforts of delivering care? In our latest findings on the EPR market, we take a close look at the top issues facing NHS trust leaders, EPR and PAS replacement rates (and the suppliers poised to win or lose as a result), and perceptions of HIT suppliers making the greatest impact in the UK.
Less than a decade after the HITECH Act sought to stimulate investment into Healthcare IT, EHRs have become a regular feature of American medicine; but problems still remain. These findings subject the EHR market to a demanding physical examination from the often ignored frontline users–physicians. We received feedback from 1,053 physicians who gave their unique perspective on the state of the market — and we determined there is nowhere for EHR suppliers to hide.
In June, Pragus (a top healthcare IT consulting firm in the Netherlands) leveraged our engagement platform to explore the dynamics between Epic and ChipSoft in the Dutch EPR market. Over roughly a two week period they received responses from 24% and 19% of these two suppliers’ customers, respectively. In the study, we asked for feedback in benchmarking both tangible and intangible value-adds with both suppliers and discovered some interesting trends. Some of the insights stands as confirmation of already held beliefs, while other insights may come as a surprise to some stakeholders.
Britain’s Brexit vote captivated the globe with strong claims about the consequences of the United Kingdom leaving the EU. “Remain” advocates argued there would be a number of negative financial consequences for operating in the UK, while “leave” advocates openly advertised that money saved could be sent straight into the National Health Service (see front cover).
Now that Brexit is a reality, we decided to find out what the people in the best place to know really think will happen to the NHS as a result. We asked and received direct feedback from 238 hospital leaders in 129 acute trusts about the consequences of Brexit. These results detail feedback from 73% of NHS hospital trusts. A big public thanks is in order for our participants and their overwhelming support of this research.
While HCAHPS is not the most exciting topic, care organizations that rely on CMS reimbursements are required to be onboard with its adoption. So, who are the top vendors in this space and how are they rated by their customers? The results are broken down by overall scores and by individual components.
To some, perception is everything; the public’s opinion of a brand can be what drives in new patients (read: customers) or puts the nail in the coffin. But to others, only feedback from actual patients or referring providers is what matters; those who have experience and are familiar with the organization can best judge it. Throughout these market insights, we consider the impact of brand reputation on top healthcare provider organizations. Which organizations are loved and which ones have work to do?
At its best, a CVIS does what it’s meant to do: it mines and reports critical cardiovascular related data, and it’s easy to use. At its worst, a CVIS produces headaches, increases costs, and generally gets in the way. These findings go straight to the source by asking chiefs of cardiology, CV department directors, and other leaders what CVIS solution can get the job done– and whether or not that solution is currently being used.
CDs are dead, point-to-point VPN may be losing steam, except in critical situations such as trauma cases, and cloud-based image sharing is all the rage. However, while the vast majority of healthcare providers know cloud-based sharing is the future, there are holdouts, namely the mega large hospitals. So, which vendors are winning the war of market share and mindshare in this space? We’ve got the skinny.
In this updated data from a similar study last year, providers shared their current opinions on what they believe the impact of alternative payment models for value-based care will be on their organizations, which areas of RCM they will most likely need to outsource, and what vendors they are considering (whether for the first time or in replacement of their current solution).
From an industry perspective, where do the most impactful (read: largest) payers shine and where are they tarnished (or just plain rusted out)? We found a few surprises. Also, if you do something crazy, like throw three massive “government-owned payers” (Medicare, Medicaid and Tricare) into the same pot as everyone else, what shakes out? We used our research engagement platform to gather specific data from nearly 800 ambulatory care leaders regarding their most and least favorite payers and specific reasons why.
We reached out to imaging and IT providers from NHS trusts across the United Kingdom to find out how they feel about their current PACS suppliers, which suppliers they think are having the greatest impact in medical imaging, and where these suppliers need to improve to stay in their good graces. The insights are pretty clear… some suppliers are exceeding their clients’ expectations while a few are on the chopping block.
Patient care and satisfaction are critical to the success and reputation of healthcare providers, but when it comes right down to it, money is still one of the most important factors. Without it, an organization simply won’t survive. That being the case, we delved into the minds of key hospital decision makers to discover the latest trends and insights in Revenue Cycle Management (RCM).
As we’ve begun trending patterns in healthcare IT, one thing is clear–purchasing intentions are fluid. This does not mean we see a complete shake-up of priorities, but when any key element of this market, such as data security, rises from the bottom of the priority list to right near the top, it’s a trend that’s impossible to ignore.
Everyone has an opinion about Epic…many love them, some think they’re trying to take over the world. So, where’s the truth? Tim over at HIStalk, utilized our Reaction research ecosystem to quickly engage directly with Epic-using executives. The feedback was unfiltered and off the record.
We reached out to 554 high-level imaging decision-makers across the country, representing 15% of imaging departments and asked them to name their favorite imaging IT and modality vendors. What makes some vendors the “best of the best,” we have the answers.
In this outreach, we asked chief executives, directors of IT, directors of finance and directors of operations within provider trusts to rank their top IT challenges and provide feedback about which suppliers of EPR and PAS solutions are providing the greatest support in meeting NHS goals.
Dive into the minds of the hospital c-suite to find out what keeps them up at night (hello, migration to value-based reimbursements) and the direction their taking their organizations. These insights were conducted over a two-week period and gathered feedback form 336 c-level executives.
With significant demand among patients for ambulatory care facilities, we decided to reach out to this group of providers to find out the direction of outpatient EHR. We’re seeing widespread adoption and successful attestation of Meaningful Use among other trends.
“OK, Google–” While speech recognition seems to be dominated by names like Siri, Cortana, and Google Now, this technology has been quietly serving a higher purpose in certain segments of healthcare. The advantages are clear–fewer record errors, improved workflow, simplified communication between IT systems, and a more direct connection between patient and specialist– but these benefits do not come without their tradeoffs.
Due to healthcare reform, emergency medicine providers are facing huge increases in patient and patient throughput and efficiency are more important than ever; emergency department information systems (EDIS) can either break or make a clinician’s workflow. In this collection, we get to the bottom of which vendors are best suited to help providers as they take on more and more patients.
In this data collection, over 350 providers spoke up about the current state of the LIS market, the type of service and functionality providers need from their LIS vendors, and where providers plan to go in the future.
According to our latest insights, the majority of hospitals are implementing software on their own hardware rather than purchasing a turnkey solution. What are the advantages and disadvantages to each approach? Which vendors do hospitals prefer to work with? Will the market ultimately move toward or away from the turnkey approach? The answers to these questions and high level data on some of the European market are found within these insights from Reaction.
How do Merge customers feel this change will impact them and how does the healthcare provider market at large view the news? We asked both groups and received some interesting feedback.
As consolidation continues, more documentation is required by physicians, which places a strain on providers’ time and causes frustration when EHR systems do not meet workflow needs. To make a long story short, within this tangled mess of regulations and the many solution offerings lies the opportunity for vendors to make it big, while also saving their clients money.
When it comes to image sharing, there are a number of different technology options that don’t play nice with one another and the marketplace has not yet settled on one solution. This is both an opportunity and a challenge for vendors as they pry healthcare’s cold hard grip on CDs.
As alternative payment models grow in number, healthcare systems are looking at cost-cutting measures to insulate themselves from the unknown. Vendors, beware. Those that fail to be innovative partners on this front are being viewed as deadwood and CFOs are about to pick up their axes.
Discover the key insights every data security vendor must know to stay relevant in the healthcare market.
During the past two weeks of March 2015, we gathered market insights on mHealth from 257 CMIOs, CMOs, marketing management, and patient access leaders. These hospital leaders provided excellent insights into what they are currently doing about engaging patients, what their plans are for the future, and what vendors and solutions they are looking at to help them.
U.S. healthcare providers are poised to spend billions in 2015 on information technology. The jobs, promotions, and bonuses of many healthcare professionals depend upon a few key questions: Where will this money be spent? Which vendors are poised to gain market share? Who will miss out?
The year is coming to a close and hospitals have 2015 on the mind. Big decisions about where to spend their money are coming so we set out to find what medical imaging technology decision-makers are looking to acquire next year. More importantly though, what companies are they looking at purchasing those systems from? This study will help vendors focus their strategies and resources on the right areas for the coming year.
What do you get when government regulators hold a big stick and dangle the proverbial carrot at the same time? The American Recovery and Reinvestment Act (ARRA). With more than $30 billion in financial incentives and equally painful penalties associated with the implementation of electronic health records (EHR), healthcare systems have found themselves in the awkward position of investing heavily in a new process that has been a “figure it out as you go” activity.
We all know that American healthcare is expensive. It’s one of the costliest expenses in our nation. Since 2012, the United States has spent at least $2.8 trillion on health care yearly. But according to all the research reports and statistical data out there, the extra funds aren’t doing us any favors; most other developed countries have significantly lower costs.
Patient engagement is arguably the most crucial element of true healthcare reform. In fact, many key industry influencers believe it is the Holy Grail of healthcare. So it’s not surprising that many healthcare provider organizations cried foul with the 10% patient engagement threshold originally mandated in Stage 2 of Meaningful Use. The pushback against the 10% level was so intense and persistent that the 10% requirement was reduced to 5%..
This study looks into the minds of healthcare professionals, gleaning their opinions and insights about what interoperability will specifically do to improve healthcare and how they feel it can be best implemented.
“With ReactionData, our response rates have gone up from 12% to 60%. This is helping us address customer concerns more efficiently and drive more business.”
President, Sectra North America
“We run a growing, fast paced IT environment in Silicon Valley with a lot of moving parts. With peer60, we’re able to keep our fingers on the market pulse with accurate and timely market data. Hats off to their team.”
Chief Operations Officer, NavisHealth